On-ward participation of a hospital pharmacist in a Dutch Intensive Care Unit reduces prescribing errors and related patient harm

Completed

• Conditions: Preventable Adverse Drug Events (ADEs); pharmacist participation; drug prescribing; Not Applicable

• Registration Number: ISRCTN92487665
• Lead Sponsor: etherlands Organisation for Health Research and Development (ZonMw) (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-08-19
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1173

Inclusion Criteria

All patients admitted to the ICU between October 3, 2005 and June 30, 2006

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The incidence of prescribing errors per 1000 monitored patient-days.

Secondary Outcome Measures

Name	Time	Method
The number of prescribing errors per 1000 monitored patient days that resulted in patient harm (preventable Adverse Drug Events).